DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Nepicastat is an investigational drug.
There have been 4 clinical trials for Nepicastat. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2008.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Biotie Therapies Inc., Ralph H. Johnson VA Medical Center, and National Institute on Drug Abuse (NIDA).
Recent Clinical Trials for Nepicastat
|A Multi-Center Trial of Nepicastat for Cocaine Dependence||National Institute on Drug Abuse (NIDA)||Phase 2|
|Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans||Baylor College of Medicine||Phase 2|
|Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans||Biotie Therapies Inc.||Phase 2|